Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 24, 2017
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
Chris Shibutani Initiated (SNDX) at Buy on, Mar 24th, 2017
Chris Shibutani of Cowen & Co., Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Buy on, Mar 24th, 2017.
Chris has made no other calls on SNDX in the last 4 months.
There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 0 agree with Chris's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Chris
- Edward White of "FBR Capital" Initiated at Buy and Held Target at $27 on, Thursday, March 16th, 2017
- Christopher Marai of "Nomura" Initiated at Strong Buy on, Thursday, March 2nd, 2017
